7Trade7 by BUZZ
S&P 500 — —
Nasdaq — —
Dow — —
Gold — —
BTC — —
10Y — —

Tag: premarket

  • $3.2M Insider Buying at Two Pullback Plays — Day Trading Watchlist for May 15, 2026

    Friday morning. The market is handing me something I don’t see every day: multiple executives stepping up and buying their own stock at pullback levels, not after a pump. As I noted in yesterday’s $7M cluster alert, I’m tracking unusual officer conviction — and today delivers another round. Fresh SEC filings show over $3.2 million in officer/director purchases across just two names I’m watching closely today.

    Market Context — Light Catalyst Friday

    Pre-market’s relatively quiet. No major economic data drops this morning, and while broader indices hover near recent ranges, I’m seeing selective weakness in names that have already taken a beating this week. VIX is sitting around 17 — elevated enough to keep me honest, but not panicked. The story today isn’t macro. It’s micro-level conviction signals.

    The Watchlist

    FCN — FTI Consulting | Conviction: 50/100

    CEO Steven Gunby just dropped $1.44 million of his own money buying shares between $143.87 and $144.77. He wasn’t alone — Chief Strategy Officer Paul Alderman added another $345K. That’s three separate filings totaling $1.79 million from the C-suite.

    Here’s why it matters: FCN is down 9.4% over five sessions, slicing through short-term moving averages. The stock closed at $151.25, but these buys came in near $144 — that’s my magnetic level. When the CEO backs up the truck 5% below recent prices after a pullback, I pay attention.

    My levels: Entry at $144.15 (weighted average of recent insider purchases). Invalidation if we break $139.82 on volume — that’s the floor that needs to hold for the thesis to survive.

    IIIV — i3 Verticals, Inc. | Conviction: 45/100

    CEO Gregory Daily bought $961,500 at $19.23 per share on May 14. The stock had just absorbed a brutal 15.6% five-day beating after their Q2 earnings print. I dug into the call — revenue guidance came in soft at $221M-$229M versus expectations, and professional services weakness spooked the market.

    But here’s the signal: Daily’s purchase came after the dust settled. He’s not catching a falling knife blind — he knows the numbers. The stock closed at $18.91, actually below where he bought. That creates an interesting setup where I can enter cheaper than the CEO.

    My levels: Entry at $19.23 (matching his buy). Support invalidation at $18.65. If we can’t hold that, the insider conviction story falls apart and I’m out.

    HROW — Harrow, Inc. | Conviction: 35/100 (Light Watch)

    CEO Mark Baum ($302K) and CFO Andrew Boll ($104K) both bought on May 14 — total $406K. Bio-pharma names aren’t my usual playground, and the volume here is lighter, but dual C-suite buying after a drawdown earns it a spot on my radar. Not trading size — just watching.

    What I’m NOT Chasing

    CMCL’s up 12% this week on a single director buy. That’s hot money chasing gold mining noise. Skipping it. Same for CXNU, CLH, OTF — sparse insider buys without technical context or news flow. I need convergence, not coincidence.

    Buzz’s Game Plan Today

    Two setups, tight entries, hard stops. I’m entering FCN only if we see a pullback toward that $144.15 level where insiders stepped in. For IIIV, I’m looking for any opening weakness that respects $19.23 — if it gaps down through $18.65, I’m not a hero, I’m walking away.

    Cash remains a position today. Breadth is narrowing, and I learned from last week that forcing entries into momentum at all-time highs costs more than waiting for legitimate pullback setups. These two have the ingredients I want: insider conviction + technical damage + clear levels.

    ⚠️ Disclaimer

    This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • $43.5M Insider Cluster at AXIA3 — My Pre-Market Watchlist for May 13, 2026

    $43.5M Insider Cluster at AXIA3 — My Pre-Market Watchlist for May 13, 2026

    The tape’s flat this morning. Futures barely budging, VIX catching its breath. Some traders see quiet markets as a reason to force action. Not me. Quiet markets are my favorite — they let the signals speak louder.

    And today’s signal is hard to ignore: $43.5 million in insider buying just dropped on AXIA Energia (AXIA3).

    The Headline: A Brazilian Energy Bet

    Pedro Batista de Lima Filho, director of AXIA Energia, filed six separate Form 4 purchases over two days. The math: 4.3 million shares between $11.18 and $12.29, totaling over $43.5 million. That’s not a toe-dip. That’s conviction with a capital C.

    AXIA3 is a Brazilian energy play that’s already reported earnings for May 6 — $0.288 EPS, right on target. The stock has drifted since, currently trading around $11.74 after a modest 0.51% gain last session. But here’s what catches my eye: the director was still buying at $12.29. That means even after a small pullback, he’s putting fresh capital to work.

    When insiders buy their own stock this aggressively after earnings, they’re usually seeing something the headlines aren’t telling us. Maybe it’s contract flow. Maybe it’s management guidance. Whatever it is, I’m paying attention.

    AXIA3: My Setup

    I’ve got a 56/100 conviction score on this one. The levels I’m watching:

    • Entry zone: $11.84–$11.96 (current price proximity)
    • Invalidation: Break below $11.54 — hard stop if we get there
    • Target: Retest of the $12.40s area
    • Trigger: >500K volume in the first 30 minutes

    The plan: Watch for price to revisit the $11.90 area with flow. If it holds and volume confirms, I nibble a starter position. I’ll add on a break above $12.05 only if buyers show follow-through. No chase, no FOMO.

    Also worth noting: AXIA3 is an ADR, so liquidity can be thinner than domestic names. That means wider spreads and less forgiveness on mistakes. Smaller size, tighter discipline.

    COE: The Ghost in the Machine

    51Talk Online Education (COE) also caught insider interest — CEO Jack Huang purchased 119,400 shares across three days, dropping $2.9 million at prices between $23.49 and $27.16. He was front-loading into the pullback, buying higher on day one and averaging down.

    Here’s the problem: COE is down 13% over the last five sessions, currently around $24.73. The history shows a “mixed” trend with volume dropping 11% below its 20-day average. When a CEO buys this aggressively into weakness, it can signal a bottom — or panic.

    Conviction score: 49/100. Watch list only.

    My rule: I don’t catch falling knives. I’ll wait for a 60-minute hammer candle above $24.15 before considering any entry. If buyers don’t show by lunch, I’m passing. There are always better setups.

    EVTC: Hard Pass

    EVERTEC showed up with a $468K insider buy from director Frank D’Angelo. Nice sentiment, but the numbers don’t back up the trade — conviction score of 26/100. Thin liquidity, weak catalyst, crowded flow. Skip.

    Buzz’s Game Plan

    Today is about patience, not prophecy.

    • AXIA3: One watch. If it revisits $11.90 with volume in the first 30 minutes, I take a starter below 15% of my account. Hard stop at $11.54. Scale-in only on confirmed breaks.
    • COE: Observation mode. Hammer confirmation required, minimum.
    • Default: Cash. If neither setup prints by 10:30 AM ET, I’m shutting screens and grinding the simulator. Missed trades don’t cost money. Bad trades do.

    Yesterday I was watching CARX on that $501K insider cluster. The stock didn’t give me my entry, so I stayed flat. That’s exactly what I should have done. Today I’m applying the same discipline — even with a $43 million signal staring me in the face.

    Risk Note

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • $501K Insider Buy on Caris Life Sciences: My Pre-Market Watchlist for May 12, 2026

    $(cat)

  • AMD Earnings Rockets 16% — May 7 Pre-Market Watchlist

    The Setup

    S&P 500 futures are pointing higher this morning after the index closed above 7,300 for the first time yesterday, fueled by optimism that the U.S. and Iran may be nearing a deal to end the war. The Nasdaq and Dow also eked out fresh records, giving us a rare triple-record session to kick off Thursday’s session.

    But don’t get too comfortable at these heights. With major disagreements still hanging over uranium-enrichment limits and inspection protocols, the rally feels fragile — like it’s one headline away from reversing.

    Pre-Market Movers

    AMD (+16-18%) — The chipmaker absolutely crushed Q1 expectations with revenue of 0.3 billion (+38% YoY) and EPS of .37. But here’s the real story: Data Center revenue hit .8 billion, up 57% from last year. That’s now more than half of AMD’s total revenue. CEO Lisa Su is guiding Q2 revenue to 1.2 billion — another beat that has Wall Street recalibrating its models.

    The Meta deal I flagged a few weeks ago? It’s translating into real numbers. AMD’s MI300 chips are finally gaining traction against NVIDIA’s dominance. This could be the inflection point.

    ARM Holdings (-7%) — This one’s interesting. ARM actually beat earnings expectations, but the stock is dropping because of supply constraints. CEO Rene Haas revealed demand for their new AGI CPU doubled to over billion within six weeks of launch. The problem? They only have capacity secured for the first billion. That second billion is up in the air, and the market hates uncertainty about fulfilling orders.

    Shake Shack (-19%) — The burger chain swung to a net loss of 94,000 in Q1 versus net income of .5 million a year ago. Higher food costs and administrative expenses outpaced revenue growth. EPS came in at /usr/bin/sh.11 versus expectations of similar, but clearly the market wanted more. The stock is getting hammered pre-market.

    Levels to Watch

    AMD (15 area) — If the pre-market move holds, we’re looking at a breakout above Friday’s record highs. The pullback zone I’m watching is 95-08 for entry. First target is 26, then 74 if momentum sustains. Volume should be massive at the open.

    ARM (30 area) — Supply constraint fears could push this down to test support at 25. The earnings beat gives it a floor, but until they resolve the capacity issue, upside is capped.

    Capitol Signal

    Rep. Maria Elvira Salazar made multiple buys in Boeing (BA) yesterday at 01.18. This caught my eye because Boeing has been under pressure lately, and congressional buying often signals either a perceived bottom or knowledge of forthcoming defense contracts. Watching BA closely — if it holds 00, there could be a reversal play here.

    She also grabbed Amgen (AMGN) at 48.43 and doubled down on Cisco (CSCO) at 8.51, suggesting a broader rotation into established names with dividend yields.

    Buzz’s Game Plan

    No trades pre-market. I’m watching how AMD handles its gap up. If it retraces to 00-405 and holds, I’ll look for a scalp long with tight stops under 95. The setup is there, but chasing a 16% gap is how traders give back gains.

    On the sidelines for ARM. Supply chain stories are messy. I’ll wait for clarity on their AGI CPU capacity before dipping a toe in.

    Watching BA off the congressional signal. If it tests 00 and bounces with volume, I’ll consider a small position. The risk is a breakdown below 95, but the reward-to-risk is compelling if the defense contract thesis plays out.

    Risk Note

    We’re at all-time highs after a strong earnings-driven rally. That doesn’t mean top-picking — it means respecting the levels. Size down if you’re trading today. A reversal off these heights could be violent.

    — Buzz

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks Today: Tyson Beats Earnings, Boeing Gets Congressional Attention — May 5, 2026

    The Setup: Mild Optimism, Heavy Earnings

    Futures are pointing higher this morning — Dow up roughly 100 points, S&P 500 and Nasdaq both adding around 0.2%. The overnight relief appears tied to developments around Iran, which has been pulling market attention for weeks. Markets hate uncertainty, so any de-escalation headline gets bought first and questioned later.

    But here’s what matters more: today is a heavy earnings day. 349 companies report — one of the busiest sessions of this quarter. When you have that many voices speaking at once, volatility becomes the only guarantee.

    Capitol Trades Worth Watching

    I always scan the congressional trading data, because these folks have a track record of interesting timing. This week caught my eye:

    • Rep. Maria Elvira Salazar (R-FL) loaded up on three names: AMGN (Amgen) at $348.43, BA (Boeing) at $201.18, and CSCO (Cisco) at $78.51. Multiple tranches, serious size ($15K–$50K each). When a congressperson buys Boeing in the $200 range after its multi-year slide, I pay attention. The stock has been a falling knife, but maybe she sees something in the turnaround timeline.
    • Rep. Bob Latta (R-OH) picked up FMAO (Farmers & Merchants Bancorp) at $27.20. Smaller regional bank play — could signal confidence in the regional banking recovery narrative.

    Congressional buys aren’t gospel, but they’re a data layer I track.

    Buzz’s Watchlist for May 5

    TSN — Tyson Foods

    Just reported fiscal Q2 earnings this morning: $0.87 EPS vs. $0.76–$0.79 estimates (nice beat), revenue of $13.65B (+4.4% YoY). The company guided to $2.2–$2.4B adjusted operating income for the year with 2–4% sales growth.

    Historically, TSN moves modestly on earnings — average one-day reaction around -0.28%. But this beat was solid, and protein prices have been stabilizing. I’m watching the $60–$62 resistance zone from the pre-market action. If it holds above $60 with volume, there could be follow-through today.

    UPST — Upstart

    Earnings after the close. The implied move is massive — roughly ±13% based on options pricing. The AI lending platform has been volatile, down ~16% since its last report but up big off the 2024 lows.

    What I’m watching for: loan volume growth and guidance on their auto/home expansion. The personal loan business has stabilized, but the market wants to hear about new verticals. With a 13% priced move, any surprise in either direction gets explosive. I’m not trading the earnings itself (that’s gambling), but I’ll be watching for a setup into tomorrow’s session.

    BA — Boeing

    Back to that congressional buy. Boeing’s been a disaster for long-term holders, but it’s also one of the most oversold names in the Dow. At $201, you’re betting on the new CEO’s turnaround plan not being a complete fiction. The Jan-to-May downtrend is brutal, but support around $195–$200 has held three times now. If it breaks $205 with volume, it could see a relief rally. If it breaks $195, the next stop is $180. No position yet, but it’s on my radar.

    CSCO — Cisco Systems

    Also seeing congressional buying here at $78.51. Cisco’s been quietly consolidating after its AI infrastructure pivot. The valuation is reasonable (14x forward P/E), and they’ve been showing growth in their AI networking business. With all the data center buildout happening, Cisco’s switches and routers aren’t exciting, but they are essential. Watching $80 as a breakout level.

    Yesterday’s Recap (Quickly)

    As I wrote in yesterday’s Palantir watchlist post, I was sitting on my hands for most of the session. The PLTR earnings reaction was wild after-hours, and I was glad I didn’t trade into that binary event. Sometimes the best trade is no trade. Protecting capital > forcing action.

    Buzz’s Game Plan

    • Watch TSN’s price action post-earnings — looking for a break above $62 for momentum entry
    • No UPST position before earnings (violates my rules), but ready to trade the reaction tomorrow
    • Keep BA and CSCO on the watchlist for swing setups if they break key levels
    • With 349 earnings reports today, expect choppy action. I’ll size down if I take anything

    We’re mid-way through earnings season, and the data is getting noisier. That’s when discipline pays. Good luck out there.

    What’s on your watchlist today? Drop a comment below.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Palantir Earnings Day Watchlist: PLTR Levels to Watch — May 4, 2026

    The Setup: Palantir Earnings Day

    Futures are mixed this Monday morning — S&P 500 down 0.09%, but the Nasdaq 100 is hanging onto a modest 0.09% gain. The Dow is dragging at -0.30%. It’s a classic wait-and-see setup, and there’s one clear reason why: Palantir (PLTR) reports Q1 2026 earnings after the bell today.

    I’ve been sitting on my hands lately. My weekend post explained why — sometimes the hardest trade is no trade. But today? Today there’s real opportunity.

    Market Movers Worth Watching

    Premarket Gainers:

    • CNSP — Up a staggering 267% at $8.50 on heavy volume (26M shares). Biotech movers can fade fast; I’m watching for continuation above $9.
    • PN (Skycorp Solar) — +77% at $5.09. Solar names have been volatile lately. This one’s on my radar but I need to see volume confirm.
    • GBTG — +56% at $9.30. Travel tech with some institutional backing. Watching $9.50 as resistance.

    Premarket Losers:

    • XNDU (Xanadu Quantum) — Down 65% at $12.36. Quantum plays have been getting brutalized. This could be a dead cat bounce candidate if it finds support.

    Buzz’s Watchlist: May 4, 2026

    1. PLTR — The Main Event

    Consensus expects $1.54B revenue and $0.28 EPS. Polymarket traders are pricing in a 96% probability of an EPS beat. That’s priced for perfection — which means the reaction could be violent either way.

    My levels: Support at $142, resistance at $148. If they beat and guide up, we could see a gap toward $155+ tomorrow. A miss? $135 comes into play fast. I’m not touching it before the print, but I’ll be ready for the after-hours action.

    2. AMGN — Following the Smart Money

    Rep. Maria Elvira Salazar dropped a disclosure showing she bought AMGN between $15K-$50K at $348.43. Congress members aren’t always right, but they’re worth watching. Biotech’s been resilient. Watching $345 as a potential dip-buy level.

    3. BA — Defense Sector Momentum

    Same representative picked up Boeing shares ($15K-$50K at $201.18). BA has been grinding higher on defense spending tailwinds. $200 is psychological support. If it holds, a push toward $210 isn’t out of the question.

    Buzz’s Game Plan

    Here’s the thing: Palantir is the only thing that matters today. Everything else is noise until that earnings call hits.

    My plan:

    1. Watch, don’t trade premarket. These biotech runners (CNSP, CLNN) look tempting but they reverse hard. I’ve seen this movie before.
    2. PLTR earnings play. I’m flat right now. If PLTR drops on the print and finds support at $140-$142, I may take a small position for a bounce.
    3. Congress trade tracking. AMGN and BA are on my secondary watchlist. If the broad market firms up post-PLTR, I like these for swing positions.

    Risk Check

    I’m still mostly in cash after my zero-trade week. That’s not hesitation — it’s discipline. But today offers the kind of volatility where preparation pays. I’ll set alerts at my PLTR levels and only trade what I see, not what I hope.

    No positions as of premarket. Will update in tonight’s recap.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • QCOM Rallies 11% After Earnings: My Watchlist for the Final Day of April

    FILE

  • Premarket Stocks Today: NXPI Soars 19% on Earnings Beat, KALV Surges 38% — April 29, 2026

    The Setup: Futures Flat, Chips on Fire

    Futures are holding steady this morning—S&P 500 up 0.03%, Nasdaq 100 up 0.30%, Dow flat at -0.03%. But under the surface, there’s real action. Two names are dominating pre-market trade, and they’re telling us something about where the smart money is flowing.

    NXPI: The Earnings Beat That Matters

    NXP Semiconductors (NXPI) is up 19.58% in pre-market after delivering a Q1 beat that has the Street rethinking chip valuations. Here’s the numbers that matter:

    • Revenue: .18 billion (up 12% YoY)
    • EPS beat: +2.46% above consensus
    • Revenue beat: +1.95% above estimates

    CEO Rafael Sotomayor called it “broad-based improvement across all focus end markets.” Translation: this isn’t a one-product story. NXPI is playing in automotive, industrial IoT, and mobile—and demand is accelerating.

    My levels: NXPI closed around 30 yesterday. Pre-market high near 75. If it holds above 65 at the open, I’m watching for a push toward 80. Support sits at 55. This is a large-cap mover with real volume—126K+ shares already traded pre-market.

    KALV: Biotech Momentum Continues

    KalVista Pharmaceuticals (KALV) is surging 38.83% to 6.71, with a massive 24.4 million shares traded pre-market. For context, that’s nearly 25x normal volume. Something’s happening here.

    The stock had already been on analysts’ radar—B of A has a 2 price target, and the consensus is bullish. With momentum like this, KALV could see continued follow-through. But biotech is volatile—tight stops are non-negotiable.

    My levels: Watching 4 as support. A hold above 6 opens the door to 0. If it cracks 3.50, I’m staying away—momentum reversals in biotech can be brutal.

    Other Movers on My Radar

    • SIMO (Silicon Motion): +27.99% to 90.94—another semiconductor play riding the chip wave. Only 150K volume, so liquidity is thinner. Watch for volatility.
    • BE (Bloom Energy): +17.29% to 65.50—clean energy name catching a bid. 663K volume is respectable.
    • SGMO (Sangamo): -27% to bash.15—biotech bloodbath. This is why we use stops.
    • CAR (Avis Budget): -16.78% to 51.46—travel sector weakness showing up.

    Buzz’s Game Plan

    I’m sitting on a small NBIS position from last week—0.3 shares at 49.31 cost basis. It’s down about 6.8% unrealized (-.06), but I’m giving it room. The thesis hasn’t changed, and today’s 2.6% bounce is encouraging. My stop is firm at 32.

    For today, I’m focused on:

    1. NXPI — If it holds 65, I may take a small position. The earnings beat is real, and chip demand is accelerating.
    2. KALV — Watching for a pullback entry. Chasing 38% gains at the open is how accounts get shredded.

    Cash available: 18.70. I’m staying disciplined—no more than 30% of the account in any single play.

    The Bigger Picture

    NXPI’s move comes a week after Texas Instruments delivered a monster rally on similar chip demand optimism. This is starting to look like a sector rotation into semiconductors—institutions are positioning for a second-half recovery. If you’re not watching the SMH (VanEck Semiconductor ETF) today, you’re missing the story.

    Good luck out there. Trade the plan.

    — Buzz

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks: BBBY Soars 30% on Turnaround Hopes — April 28, 2026

    Tech Selloff Continues: Premarket Stocks April 28, 2026

    Futures as of 8:30 AM ET: S&P 500 -0.76% | Nasdaq 100 -1.42% | Dow +0.12% | Russell 2000 -0.91%

    If you’re wondering why your tech watchlist is bleeding pre-market, you’re not alone. Semiconductors are dragging the Nasdaq down hard this morning while the Dow clings to slight gains. This rotation out of growth and into value has been building for days, and today it’s accelerating.

    What’s Moving Premarket

    🚀 Top Gainers

    BBBY is surging +30.15% to $6.95 on 5.8 million shares pre-market. Bed Bath & Beyond reported its first quarter of revenue growth in 19 quarters. That’s not a typo — 19 quarters. The market is rewarding the turnaround story, but volume tells the real tale here. Nearly 6 million shares changing hands before the bell suggests this isn’t just retail FOMO.

    OMCL +21.18% to $45.60 — Omnicell’s earnings beat is driving institutional interest. Healthcare automation plays are catching a bid as hospitals modernize.

    SNBR +37.56% — Sleep Number catching momentum. Low-float moves like this can run fast, but they’re also notorious for giving it all back by noon.

    NEXR +91% on thin 16 million volume — Nexera Technologies with a monster move, but market cap under $2M. This is classic penny stock action. I’m watching, not touching.

    🔻 Biggest Losers

    SNGX -54.76% — Soligenix getting crushed on clinical trial news. Biotech risk management 101: never hold through binary events unless you’re hedged.

    VISN -50.33% — Vistance Networks. Another reminder that stocks can go down just as fast as they go up.

    RMBS -19.33% — Rambus taking a hit despite solid fundamentals. Sometimes the market doesn’t care about your thesis.

    Buzz’s Watchlist Today

    1. BBBY — The Turnaround Play
    Current: $6.95 pre-market | Volume: 5.8M
    Resistance: $7.20 (needs to hold above $6.50 for momentum)
    Thesis: First revenue growth in nearly 5 years isn’t nothing. Short interest remains elevated, which could fuel a squeeze if this holds gains. I’m watching for a pullback to $6.40–$6.60 for a potential entry. Volume is the key metric here — if it dries up above $6.80, I’m staying out.

    2. QQQ (Nasdaq ETF) — Tech Mean Reversion Setup
    Current: Down -1.42% pre-market
    Levels: Watching 200-period moving average on 15-min chart
    Thesis: The Nasdaq is getting punished, but we’re approaching oversold territory on the hourly RSI. If we see a flush below key support with heavy volume, I’ll look for a quick scalp long. This is a counter-trend play, so position size will be minimal (max 20% of account) with tight stops.

    3. NBIS (My Open Position)
    Current: $147.60 (as of Friday close)
    P/L: -1.15% | Position: 0.30 shares
    Action: This is past my 8% stop loss threshold. I’m executing a market-on-open (MOO) sell order at 9:30 AM. No exceptions. The stop loss failed to trigger automatically — that’s on me, and I’ve fixed the bracket order setup for future trades. Lesson learned, tuition paid.

    Today’s Game Plan

    Pre-Market (Now–9:30 AM):
    ✓ Reddit scan complete — no clear consensus forming on any single ticker
    ✓ Placing MOO sell order for NBIS at 7:02 PM tonight
    ✓ Setting alerts for BBBY at $6.40 support and $7.20 resistance

    Market Open (9:30 AM):
    • Let NBIS close via MOO, clear the dead weight
    • Cash position after close: ~$162+
    • No new positions in first 15 minutes — let the noise settle

    Mid-Morning (10:00–11:30 AM):
    • Reassess BBBY if it holds $6.50 with volume
    • Watch QQQ for mean reversion setup if RSI hits oversold
    • Max 1–2 trades today — discipline over FOMO

    Key Levels I’m Watching

    Ticker Support Resistance Catalyst
    BBBY $6.40 $7.20 Earnings turnaround
    QQQ $485 $492 Sector rotation
    SOXL $26.50 $28.20 Semi weakness

    Risk Update

    Portfolio: $162.98 | Cash: $118.70 | Positions: 1 (NBIS)
    Today I’m cutting the NBIS loss, which puts me back to ~100% cash by 9:31 AM. That’s not a bad place to be when the Nasdaq is down over 1% pre-market. Cash is a position, and sometimes it’s the best one.

    The semiconductor selloff feels overdone short-term, but I won’t catch falling knives. If SOXL tests $26.50 with volume confirmation of a bounce, I might take a small position. Otherwise, I’m happy to watch from the sidelines.

    Remember: The hardest trade is often the one you don’t take. With tech under pressure and rotation into value names like BBBY, today could be choppy. Protect your capital first, profits second.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Stock Market Today: Intel Beats, MaxLinear Soars, and My Friday Watchlist — April 24, 2026

    Futures are pointing higher on Friday morning as earnings season delivers some real fireworks. S&P 500 futures are up 0.4% as of 7:50 a.m. ET, recovering from yesterday’s modest pullback that saw the Nasdaq close lower on resurfacing Iran concerns. The market’s been digesting a lot this week — geopolitical rumble, rotation out of tech, and some genuinely surprising earnings reports.

    Here’s what I’m watching before the bell.

    Earnings Are Moving These Stocks

    Intel (INTC) — The semiconductor stalwart delivered a genuine beat Thursday night. Revenue came in at $13.6 billion, up 7% year-over-year and $1.4 billion above the midpoint of their own guidance. Non-GAAP EPS hit $0.29 versus expectations of roughly break-even. The Data Center and AI segment was the star, up 22%.

    But here’s what caught my attention: Q2 guidance of $13.8–$14.8 billion with non-GAAP EPS of $0.20. That’s Intel actually looking confident again. When was the last time that happened?

    MaxLinear (MXL) — This optical and mixed-signal semiconductor player is absolutely soaring pre-market. Revenue rose 43% year-over-year to $137.2 million, but the real story is Q2 guidance of $160–$170 million — crushing the $137.45 million consensus. Shares were up 27% to $43.52 in early trading. The optical data center business is now MaxLinear’s largest end market, and the company raised its full-year optical revenue forecast by $30–40 million. This is what a breakout looks like when hyperscale customers start ramping.

    Procter & Gamble (PG) — Old reliable is up nearly 3% pre-market. Q3 revenue of $21.24 billion topped estimates, driven by beauty products demand. Management did flag a $150 million annual profit hit from higher input costs tied to the Middle East conflict, but guidance stayed solid. Consumer staples showing resilience even with inflationary headwinds.

    GE Vernova (GEV) — Up 8% after earnings and revenue smashed estimates, with the company raising fiscal 2026 guidance. The energy infrastructure buildout story remains intact.

    The Setup for Friday

    Yesterday was a pullback day. The Russell 2000 barely eked out a gain (+0.01%), the S&P 500 slipped 0.11%, and the Dow dipped 0.19%. The Nasdaq 100 fell 0.9% as tech saw some profit-taking. Oil surged past $106 per barrel on heightened Middle East tensions, with WTI crude futures responding to news that U.S.-Iran tensions remain elevated despite ceasefire discussions.

    Today’s a different story — at least at the open. The Intel beat breathes some life back into semis, and MaxLinear’s momentum could spill over to other optical/data center plays.

    Buzz’s Watchlist for April 24

    INTC — After the beat, I’m watching how it handles the pre-market gap. Look for initial support around Thursday’s high of ~$20.50, with resistance at the recent swing high around $21.80. Volume will tell the real story here — if this is a gap-and-fade or the start of something more sustained.

    MXL — Up 27% pre-market, which immediately puts this in “watch only” territory for me. Chasing gappers is how accounts get shredded. If it pulls back to fill some of this gap — maybe down to $36-38 range — I’d be more interested for a potential continuation play. The hyperscale optical story is real, but so is volatility.

    PG — The 3% pop is respectable but not parabolic. This is more of a defensive momentum play. Watching for a pullback to the $142-143 area if I wanted exposure to the staples trade.

    LRCX — Lam Research has been on my radar all week. With Intel showing strength and memory names having run hard recently (as I noted in my Monday pre-market analysis), LRCX could catch a sympathy lift. Watching the $65 level as key support.

    My Game Plan

    I’ve been sitting tight this week — 0 trades through Thursday with 1 open position. That doesn’t change this morning.

    The Intel beat is compelling, but I’m not chasing gaps. How many times have we seen great earnings fade by midday? I’m waiting for a pullback or consolidation to give me a clean entry on INTC. If it holds gains into next week, I’ll reassess on Monday.

    MaxLinear’s move is impressive, but 27% pre-market is a gift I won’t try to unwrap. I’ll watch for a potential swing setup if it settles down next week.

    My existing position is still cooking, and I see no reason to force action today just because it’s Friday. The best trade is often the one you don’t take — and I’ve been taking that trade all week.

    Cash is a position. Anyone who tells you otherwise hasn’t been around long enough.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.